{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "1718814", "DateCompleted": {"Year": "1991", "Month": "12", "Day": "06"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0306-3623", "JournalIssue": {"Volume": "22", "Issue": "4", "PubDate": {"Year": "1991"}}, "Title": "General pharmacology", "ISOAbbreviation": "Gen Pharmacol"}, "ArticleTitle": "Some substances with proposed digitalis-like effects evaluated on platelet functions sensitive for cardiac glycosides.", "Pagination": {"StartPage": "749", "EndPage": "753", "MedlinePgn": "749-53"}, "Abstract": {"AbstractText": ["1. The effects of progesterone, corticosterone 21-acetate, chlormadinone acetate, dehydroepiandrosterone 3-sulfate and lysophosphatidylcholine were tested on 86Rb-uptake, 3H-5-HT-uptake, ADP-induced aggregation and 5-HT-induced shape change in human platelets. Ouabain and digoxin were used for reference. 2. Ouabain and digoxin 10(-5) M inhibited 86Rb-uptake by more than 85%, and chlormadinone acetate 10(-5) M by 20%. The other substances had no effects. 3. Ouabain and digoxin were potent inhibitors on 3H-5-HT-uptake, whereas chlormadinone acetate had no effect. 4. Ouabain and digoxin increased ADP-induced aggregation but chlormadinone acetate decreased it. 5-HT-induced shape change was decreased by ouabain and digoxin, and to a lesser extent by chlormadinone acetate and its vehicle (ethanol 1.0%)."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacology, Lund University Hospital, Sweden."}], "LastName": "Andersson", "ForeName": "T L", "Initials": "TL"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Zygmunt", "ForeName": "P", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Vinge", "ForeName": "E", "Initials": "E"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Gen Pharmacol", "NlmUniqueID": "7602417", "ISSNLinking": "0306-3623"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cardiac Glycosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Lysophosphatidylcholines"}, {"RegistryNumber": "0SY050L61N", "NameOfSubstance": "Chlormadinone Acetate"}, {"RegistryNumber": "333DO1RDJY", "NameOfSubstance": "Serotonin"}, {"RegistryNumber": "459AG36T1B", "NameOfSubstance": "Dehydroepiandrosterone"}, {"RegistryNumber": "4G7DS2Q64Y", "NameOfSubstance": "Progesterone"}, {"RegistryNumber": "57B09Q7FJR", "NameOfSubstance": "Dehydroepiandrosterone Sulfate"}, {"RegistryNumber": "5ACL011P69", "NameOfSubstance": "Ouabain"}, {"RegistryNumber": "73K4184T59", "NameOfSubstance": "Digoxin"}, {"RegistryNumber": "EC 7.2.2.13", "NameOfSubstance": "Sodium-Potassium-Exchanging ATPase"}, {"RegistryNumber": "KN17U0V6BL", "NameOfSubstance": "corticosterone acetate"}, {"RegistryNumber": "MLT4718TJW", "NameOfSubstance": "Rubidium"}, {"RegistryNumber": "W980KJ009P", "NameOfSubstance": "Corticosterone"}], "MeshHeadingList": [{"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Blood Platelets"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cardiac Glycosides"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Chlormadinone Acetate"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Corticosterone"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Dehydroepiandrosterone"}, {"QualifierName": [], "DescriptorName": "Dehydroepiandrosterone Sulfate"}, {"QualifierName": [], "DescriptorName": "Digitalis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Digoxin"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Lysophosphatidylcholines"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ouabain"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Plants, Toxic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Platelet Aggregation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Progesterone"}, {"QualifierName": ["pharmacokinetics"], "DescriptorName": "Rubidium"}, {"QualifierName": ["metabolism"], "DescriptorName": "Serotonin"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Sodium-Potassium-Exchanging ATPase"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1991", "Month": "1", "Day": "1"}, {"Year": "1991", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1991", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1718814", "10.1016/0306-3623(91)90090-s", "0306-3623(91)90090-S"]}}]}